Stock markets continue the week with little movement (waiting for the quarterly season to start tomorrow), divided between hopes of recovery, inflationary pressures in the United States and the stop and go to some vaccines. In particular, the Johnson & Johnson serum has been suspended by the stars and stripes health authorities for rare cases of thrombosis. A script similar to the one seen for AstraZeneca in Europe. Meanwhile, however, J&J has decided to "proactively delay" the launch of its anti-Covid vaccine also in the Old Continent.
Business Square closed the session up 0,59% at 24.600 points, supported by Amplifon +6,89%, Interpump +2,8%, Campari +3,08%. Well the Agnelli galaxy. Exor appreciates by 2,16%, with Stellantis +1,39% and Cnh +0,85%, on which the rumors for the sale of Iveco to the Chinese are divided.
Out of the main basket, the publishing sector returns buoyant with Class +15,99 and Gambero Rosso, +22,45. The Ferragni effect continues on Tod's, which today makes a further leap of 5,89%. Salvatore Ferragamo also did well in fashion (+2,76%) on the expectations of the quarterly results of Lvmh (+0,86%) in Paris today.
The secondary is instead in red, where the ten-year BTP rate rises to +0,76% and the spread with the Bund of the same duration widens to 105 basis points (+2,2%). The Treasury also pays the price in the morning auctions with rising yields on 3, 10 and 15-year BTPs. The three-year (expiring in April 2024) rises to -0,17% from -0,22% of the March placement; the 2026-year bond (June 0,12, with a residual maturity of five years) goes to 0,05% from 15% in March. The 2037-year BTP rate (March 1,26) rose to 1,05% from 11,177% at the November auction. The total demand reached 7,75 billion and all the XNUMX billion euros envisaged were placed.
In the rest of Europe Frankfurt appreciated by 0,2%, Paris +0,36%, Amsterdam +0,18%, Madrid -0,08%, London +0,03%. Wall Street opened mixed and is continuing the session in the same way: the DJ is down slightly, the Nasdaq is up, while the S&P500 floats on the edge of parity.
The macroeconomic agenda is rich, starting with the United States, where inflation seems to be heating up. Consumer prices in March grew by 0,6%, the highest in 9 years. The "core" figure, excluding the food and energy prices component, marks +0,3%. On an annual basis, the general figure is +2,6%, up from 1,7% in the previous month and the highest since August 2018, with the "core" figure growing from 1,3% to 1,6 %.
Following these numbers, the euro returned above 1,19 against the dollar (currently 1,1936). Bitcoin has updated its record above $63.000 (at the moment it is in the $63.341 area), awaiting the listing on the Nasdaq tomorrow of Coinbase Global, the group that controls the cryptocurrency exchange platform of the same name.
Among commodities, gold and oil futures appreciate. The June 2021 contract of the precious metal rises by 0,6% to 1743,10 dollars an ounce.
Brent, again in June 2021, grew by 0,77% to 63,77 dollars a barrel. Supporting the crude oil market sentiment are data from China this morning. China's exports grew at a rapid pace in March in a further boost to the nation's economic recovery as global demand surged thanks to advances in COVID-XNUMX vaccinations. Import growth in the Celestial Empire also rose to a four-year high.
In clear excuse are the European macro data. The Zew index, which measures the expectations of German companies, disappointed forecasts: in April it stood at 70,7 against 76,6 in March, disappointing market expectations by 79 points. In Great Britain there was a 0,4% growth in GDP in February, still affected by the lockdown, with positive signs, however, from +1% in industrial production, above expectations.
In Italy, Istat released the update on industrial production in February (+0,2% monthly growth) and the monthly note on economic performance.
In Piazza Affari, the blue chips that suffered the most in the session are Diasorin, -1,31%, returning from a leap close to 10% yesterday, following the announcement of an agreement for the acquisition of the American diagnostics company molecular Luminex Corporation for a cash price of $37 per share.
Profit-taking also penalizes managed savings: Azimut -0,99%; Banca Mediolanum -0,86%. Weakness for Leonardo -0,54% and Telecom -0,48%.
Reuters writes that the government intends to raise the funds allocated, under the Recovery Plan, to around 6,7 billion to promote the development of broadband, 5G and satellite networks compared to the 4,2 billion envisaged in the draft approved in January. The executive is also preparing alternative scenarios to the 'single network' plan promoted by the Conte government, which aims to integrate the fixed access networks of Telecom and Open Fiber, controlled by Enel (+0,48%) and Cassa Depositi e Prestiti.
The banks moved little. The best is Intesa +0,6%. Slight drop for Unicredit -0,2%.
